Get the Stockscreener App
380.26
0.27%
1.04
Pre-market:
379.02
-1.24
-0.33%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $380.26, with a volume of 1.78M.
It is up +0.27% in the last 24 hours and up +24.63% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$379.22
Open:
$374.04
24h Volume:
1.78M
Relative Volume:
1.06
Market Cap:
$45.65B
Revenue:
$137.20B
Net Income/Loss:
$1.15B
P/E Ratio:
40.70
EPS:
9.3439
Net Cash Flow:
$1.27B
1W Performance:
+6.82%
1M Performance:
+24.63%
6M Performance:
+38.41%
1Y Performance:
+61.63%
1-Day Range:
$363.79
$380.79
1-Week Range:
$355.30
$380.79
52-Week Range:
$163.11
$380.79
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
380.26 | 45.65B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
411.04 | 373.28B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
100.68 | 128.46B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
401.89 | 87.28B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
293.83 | 77.73B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc.HUM - Business Wire
Humana employees donate $1.4M - The Business Journals
UBS reiterates Humana stock rating on utilization trends By Investing.com - Investing.com Canada
UBS reiterates Humana stock rating on utilization trends - Investing.com
Top Medicare Advantage plans deny up to 80% of rehab requests - TechTarget
Jim Cramer on Humana: “This Is a Textbook Safety Stock” - Insider Monkey
JPMorgan and Mizuho Raise Humana (HUM) Price Targets as Managed Care Outlook Improves - Insider Monkey
Billionaire Larry Robbins’ 10 Dividend Stock Picks - Insider Monkey
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, L - The National Law Review
2026-06-14 | Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:HUM | Press Release - Stockhouse
Mizuho Raises its Price Target on Humana (HUM) - Yahoo Finance
Humana Signs Agreement to Divest Minority Interest in Gentiva - Digital Health News
Columbus Hill Capital Management L.P. Has $24.83 Million Holdings in Humana Inc. $HUM - MarketBeat
Humana Stock 8-Day Winning Spree: Stock Climbs 18% - Trefis
Humana Q1 2026 Earnings: EPS Surpasses Estimates, Shares RiseMargin Guidance - newsline.com
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
CVS, Humana, and UnitedHealth Face Medicare Advantage Approval C - GuruFocus
Sustainable Insight Capital Management LLC Buys 4,740 Shares of Humana Inc. $HUM - MarketBeat
Diamond Hill Small-Mid Cap Fund's Humana Inc(HUM) Holding History - GuruFocus
Humana Reshapes Care Exposure With Gentiva Exit And Illinois Medicaid Win - Yahoo Finance
Humana Stock Rockets 15% With 7-Day Winning Streak - Trefis
Humana Stock 7-Day Winning Spree: Stock Climbs 15% - Trefis
5 Best Turnaround Stocks to Buy in 2026 - Insider Monkey
Humana Inc. stock rises Thursday, still underperforms market - MarketWatch
Humana to sell Gentiva stake in $900M deal - The Business Journals
Humana to sell off minority stake in end-of-life care provider Gentiva - Fierce Healthcare
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit - Yahoo Finance
Humana divests interest in end-of-life provider Gentiva valued at $900M - Healthcare Dive
Cantor reiterates Humana stock rating on Illinois Medicaid win By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Humana stock rating on Illinois Medicaid win - Investing.com
Evercore ISI Raises Price Target on Humana to $370 From $250, Maintains In Line Rating - marketscreener.com
Analyst recommendations: Chewy, CME Group, Ford Motor, Fortinet, Humana… - marketscreener.com
Humana and CenterWell Employees Raise $1.4 Million in 24-Hour Charity Drive - geneonline.com
Humana Stock 6-Day Winning Spree: Stock Climbs 14% - Trefis
Medicare Advantage plans denied prior authorization requests at unusually high rates, HHS report finds - NBC News
Humana Apparels boosts capacity 15% with Coats Digital solution - Fibre2Fashion
Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours - StreetInsider
Humana (HUM) to Divest Minority Stake in Gentiva for $900 Millio - GuruFocus
Humana divests minority stake in hospice provider Gentiva - Reuters
Humana To Divest End-Of-Life Care Business For $900 Million - Forbes
Humana to divest minority interest in Gentiva - McKnights Home Care
Humana (HUM) to Sell Minority Stake in Gentiva for Approximately $900M - GuruFocus
Humana to sell Gentiva stake for about $900 million - Investing.com
Humana Divests 40% Stake in Gentiva in $900M Deal - Hospice News
Humana to sell Gentiva stake for about $900 million By Investing.com - Investing.com Canada
Humana to sell minority stake in Gentiva for $900 million - StreetInsider
Humana Announces Agreement to Divest Minority Interest in Gentiva - Business Wire
Humana (HUM) Has a CenterWell-and-Care-Delivery Engine Bigger Than a Pure Medical-Cost Debate - AlphaStreet
Humana's CenterWell Employees Raise $1.4 Million in Charity Even - GuruFocus
What really keeps patients coming back to the same dentist? - Humana
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.75%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):